Home › Funds › Bellevue Group AG › IMCR

Bellevue Group AG position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

Bellevue Group AG reported holding 2,788,245 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q2 2026 13F filing — a position valued at US$88.5M, representing 1.86% of its reported portfolio and ranking #18 among its reported holdings. Bellevue Group AG has disclosed IMCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.79M sh
Reported value held$88.53M
Portfolio Weight1.86%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's IMCR position evolved

Bellevue Group AG first disclosed a stake in IMCR in Q3 2023 at 19,850 shares (US$1.0M). The position peaked in Q3 2025 at 2,796,803 shares, worth US$101.6M. Across 12 filings, Bellevue Group AG increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 2,788,245 shares valued at US$88.5M. Notable position changes include a 4817% increase in Q4 2023 (shares fell 5% over the following quarter), a 100% increase in Q2 2025 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 19.85K $1.03M New
Q4 2023 976.05K $66.68M Add
Q1 2024 972.25K $63.20M Hold
Q2 2024 1.15M $39.13M Add
Q3 2024 1.21M $37.53M Add
Q4 2024 1.21M $35.56M Hold
Q1 2025 1.22M $36.25M Add
Q2 2025 2.44M $76.62M Add
Q3 2025 2.80M $101.61M Add
Q4 2025 2.80M $97.08M Hold
Q1 2026 2.80M $84.32M Hold
Q2 2026 2.79M $88.53M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 31 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), TANG CAPITAL MANAGEMENT LLC (US$84.1M), Vestal Point Capital, LP (US$57.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has Bellevue Group AG held IMCR?

Bellevue Group AG has disclosed IMCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Bellevue Group AG's current position in IMCR?

As of Q2 2026, Bellevue Group AG holds 2.79M shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $88.53M, representing 1.86% of its reported portfolio and ranking #18.

Has Bellevue Group AG been buying or selling IMCR?

In the latest 13F filing (Q2 2026), Bellevue Group AG held unchanged its position in IMCR. The position peaked in Q3 2025 at 2.80M shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, Vestal Point Capital, LP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.